EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antimicrobial Resistance, Biofilm Formation, and Phylogenetic Distribution of Escherichia coli in Hospitalized Patients with Community-Onset Urinary Tract Infections in Western Mexico

Luis Asdrúval Zepeda-Gutiérrez iD, Sol Ramírez-Ochoa, Mauricio Alfredo Ambriz-Alarcón iD, Enrique Cervantes-Pérez iD, Araceli Castillo-Romero iD, Karel Cesar Licona-Lasteros, Rafael Cortés-Zárate iD

Antibiotics · 27.05.2026 · 15 (6) · 541

DOI: 10.3390/antibiotics15060541 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antibiotics, online erschienen am 27.05.2026. Verfasst von Luis Asdrúval Zepeda-Gutiérrez und 6 weiteren Autor:innen. Beteiligte Einrichtung: Programa de Maestría en Microbiología Médica, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Jalisco, M…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Escherichia coli is the predominant pathogen in community-onset urinary tract infections (UTIs) requiring hospitalization. This study characterized antimicrobial resistance profiles, biofilm formation, extended-spectrum β-lactamase (ESBL) gene distribution, and phylogenetic background of E. coli isolates from hospitalized UTI patients in Western Mexico.

Methods

Seventy isolates (September 2023–September 2024) underwent susceptibility testing (CLSI M100, 35th edition), multiplex PCR for blaTEM, blaCTX-M, and blaSHV genes, crystal violet biofilm quantification, and Clermont quadruplex PCR phylotyping. Associations were evaluated by Fisher’s exact test with Benjamini–Hochberg FDR (BH-FDR) correction.

Results

ESBL phenotype and MDR were detected in 57.1% and 58.6% of isolates. After BH-FDR correction, ESBL production was significantly associated with amikacin (OR = 5.55; 95% CI: 1.80–18.74; q = 0.002) and TMP-SMX non-susceptibility (OR = 3.00; 95% CI: 1.02–9.23; q = 0.036); ciprofloxacin non-susceptibility was linked to MDR status (OR = 7.21; 95% CI: 1.28–75.66; q = 0.017) but not ESBL phenotype. Biofilm was detected in 77.1% of isolates. blaTEM predominated among ESBL producers (85.0%). Phylogroup B2 (51.4%) was inversely associated with recurrent UTI on both univariate (OR = 0.17; 95% CI: 0.03–0.73; p = 0.008) and adjusted analysis (adjusted OR = 0.19; 95% CI: 0.05–0.81; p = 0.025). Phylogroup C (22.9%) exhibited the highest MDR prevalence (81.3%) and the highest biofilm formation rate among phylogroups (87.5%).

Conclusions

The high prevalence of ESBL-producing and MDR E. coli, combined with an unexpected predominance of blaTEM, reveals a distinctive local resistance landscape diverging from regional trends. The inverse association of phylogroup B2 with recurrence and TMP-SMX resistance reinforces the clinical value of phylogenetic surveillance in guiding UTI management strategies.

Schlagwörter

Stichwörter der Autor:innen

ESBLEscherichia coliantimicrobial resistancebiofilm formationmultidrug resistancephylogenetic groupsurinary tract infection

Autor:innen und Institutionen

  • Programa de Maestría en Microbiología Médica, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Jalisco, Mexico.
  • Departamento de Medicina Interna, Hospital Civil de Guadalajara Fray Antonio Alcalde, Universidad de Guadalajara, Guadalajara 44280, Jalisco, Mexico.
  • Centro de Investigación de Enfermedades Infectocontagiosas, Departamento de Microbiología y Patología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Sierra Mojada 950, Col. Independencia, Gua…
  • Laboratorio de Sistemas Biológicos, Departamento de Ciencias de la Salud, Centro Universitario de los Valles, Universidad de Guadalajara, Carretera Guadalajara-Ameca Km. 45.5, Ameca 46600, Jalisco, Mexico.

ORCID-Profile: Luis Asdrúval Zepeda-Gutiérrez, Mauricio Alfredo Ambriz-Alarcón, Enrique Cervantes-Pérez, Araceli Castillo-Romero, Rafael Cortés-Zárate

Zitieren

APA

Zepeda-Gutiérrez, L. A., Ramírez-Ochoa, S., Ambriz-Alarcón, M. A., Cervantes-Pérez, E., Castillo-Romero, A., Licona-Lasteros, K. C., & Cortés-Zárate, R. (2026). Antimicrobial Resistance, Biofilm Formation, and Phylogenetic Distribution of Escherichia coli in Hospitalized Patients with Community-Onset Urinary Tract Infections in Western Mexico. Antibiotics, 15(6), 541. https://doi.org/10.3390/antibiotics15060541

Vancouver

Zepeda-Gutiérrez LA, Ramírez-Ochoa S, Ambriz-Alarcón MA, Cervantes-Pérez E, Castillo-Romero A, Licona-Lasteros KC, et al. Antimicrobial Resistance, Biofilm Formation, and Phylogenetic Distribution of Escherichia coli in Hospitalized Patients with Community-Onset Urinary Tract Infections in Western Mexico. Antibiotics. 2026;15(6):541. doi:10.3390/antibiotics15060541

BibTeX
@article{ZepedaGutirrez2026,
  author = {Zepeda-Gutiérrez, Luis Asdrúval and Ramírez-Ochoa, Sol and Ambriz-Alarcón, Mauricio Alfredo and Cervantes-Pérez, Enrique and Castillo-Romero, Araceli and Licona-Lasteros, Karel Cesar and Cortés-Zárate, Rafael},
  title = {Antimicrobial Resistance, Biofilm Formation, and Phylogenetic Distribution of Escherichia coli in Hospitalized Patients with Community-Onset Urinary Tract Infections in Western Mexico},
  journal = {Antibiotics},
  year = {2026},
  volume = {15},
  number = {6},
  pages = {541},
  doi = {10.3390/antibiotics15060541}
}
Kostenlos starten →